Just weeks after being hit with an FDA warning letter for its manufacturing operations in Illinois–problems that led to the death of the deal–Akorn today reported that it has received a citation on another of its U.S. facilities. More: Third
read moreAfter a seemingly vain attempt to appeal to Catalyst Pharma’s conscience, Sen. Bernie Sanders, I-Vt., has asked the FDA to allow unbranded versions of Firdapse to be distributed as they had been for decades before the new drug’s approval. But
read moreThere are clear signs of health in the biopharma industry, say analysts at Vantage in their 2018 sector review. But if the animosity toward the industry in Washington yields legislation that limits price hikes, that will put pressure on the
read morePharma companies often face scrutiny on price hikes for old drugs, but now investors are challenging Novartis about high launch prices for groundbreaking new cell and gene therapies. More: Novartis' shift to superpricey cell and gene therapies draws investor ire
read moreEndo and its Par sterile injectables subsidiaries on Wednesday said a $190 million agreement to buy Somerset Therapeutics had been terminated without penalties because it was taking too long to complete. More: Endo terminates 0M deal for sterile injectable player
read moreThe CMA has provisionally found that Auden Mckenzie and Waymademay entered into illegal anti-competitive agreements regarding the supply of hydrocortisone tablets. More: Auden Mckenzie and Waymade accused of illegal hydrocortisone agreement Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals